QIAGEN powered by

Webinars and events

Loading Events

« All Events

  • This event has passed.

Authenticated and reproducible cell line ‘omics data

March 12, 2023 @ 12:00 am - 11:59 pm

Have you ever tried to access the genomic profiles of cell lines before using them in your preclinical experiments just to come up empty-handed? Maybe you’ve scoured public databases for gene expression information on your cell line to find the reported genomic profile doesn’t match the cell line data you recently purchased?

We understand that knowing the genomic identity of your cell lines is fundamental to the success of your preclinical experiments. Unfortunately, most publicly available sources have little or no cell line’ omics data, leaving you to fend for yourself.

That’s why we’ve teamed up with ATCC, the market leader in global biological materials and authenticated cell lines, to deliver you manually curated cell line ‘omics data from the most popular cell lines offered by ATCC. We’ve collected this data into ATCC Cell Line Land, our continually growing database of cell line ‘omics data from both common and novel human and mouse cell lines, primary tissues and cells from ATCC. ATCC Cell Line Land gives you access to standardized, authenticated and reproducible cell line ‘omics data characterizations which can be traced back to physical lots of cells in ATCC’s biorepository.

Attend our joint webinar with ATCC to learn about and explore ATCC Cell Line Land, including:

  • The key limitations of public cell line data that drove its development
  • How we curate our data in the QIAGEN OmicSoft Lands framework
  • Why you can depend on the provenance of the data
  • The different types of ‘omics data and metadata available
  • How it empowers you to plan and design your preclinical experiments more precisely
  • How to identify specific cell lines that express your gene of interest and those that don’t
  • How to validate specific mutations from the literature

Who should attend? Biologists, preclinical researchers, bioinformaticians, data scientists

Click here to register.

Details

Date: March 12, 2023
Time:
 12:00 am - 11:59 pm
Register for event
Event Categories:
,

Organizer

Organizer Information

TestName
Phone:
0000000
Email:
test@test.test
View Organizer Website

Other

Category
Discovery, Webinar

Venue

Virtual – Americas – EST
United States + Google Map
Register for event

On-demand Webinars


  • Supercharge your AI in drug discovery with high-quality biomedical data

    If you’re working in pharma or biotech, you likely rely on artificial intelligence (AI) to help you identify new drug targets or plausible biomarkers for disease within large data sets. Yet AI alone isn’t enough. A large proportion of Biomedical data have errors and are unstructured. For AI models to provide reliable insights, the underlying data must be of ‘hig...

  • Scale up NGS bioinformatics analysis throughput with QIAGEN CLC Genomics cloud computing

    Scale your NGS analysis to match your sequencing throughput using our QIAGEN CLC Genomics cloud solution. In this webinar, you’ll learn about the flexible and powerful setup for running your NGS sequence analyses on Amazon Web Services (AWS). You’ll learn how to use QIAGEN CLC Genomics Workbench to customize workflows and send analyses to AWS Batch for execution. ...

  • QIAGEN Biomedical Knowledge Base: Data- and analytics-driven drug discovery

    Biomedical relationships knowledge is now required for innovative data- and analytics-driven drug discovery. It powers biomedical knowledge graph analysis, artificial intelligence (AI)-driven target identification and many more applications. In this one-hour training, you’ll get an introduction to QIAGEN Biomedical Knowledge Base. You’ll learn how to tackle appli...

  • Part 1: AI-Powered Hereditary Disease Diagnostics: Closing the Gap in Clinical Exome Completeness

    Clinical exome sequencing (CES) is increasingly being adopted by small and mid-sized laboratories to diagnose genetic diseases, aid treatment decisions, and provide prognostic information. However, the exponential increase in genetic data generated from exome and genome panels poses significant workflow challenges. The ability to prioritize potentially pathogenic vari...

  • A breakthrough for rare disease: Completing the Clinical exome gap!

    In its latest release, QCI Interpret for Hereditary extends its market-leading content with further advancements in Artificial Intelligence (AI) for enhanced capabilities in clinical exome NGS testing. Now, with the addition of AI-derived literature references for rare disease genes, QCI Interpret provides complete exome coverage, on top of the existing unrivalled man...

  • What’s new in QIAGEN IPA Fall Release 2023?

    Interested in learning about new features and functionalities that have been added to IPA lately? During this webinar, we will highlight the updates from the QIAGEN IPA Fall Release and from previous releases from this year. Topics, amongst others, will be • Newly added findings and pathways • Reactome pathways • Artificial intelligence approves to pathways ...